Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
暂无分享,去创建一个
John L. Johnson | David G. Sterling | Daniel E. Zak | D. Zak | A. Aderem | M. Hatherill | T. Scriba | W. Hanekom | H. Mahomed | L. Amon | S. Suliman | W. Boom | U. Ochsner | E. Nemes | T. Hraha | A. Penn-Nicholson | M. A. De Groote | Mzwandile Erasmus | F. Darboe | E. Thompson | Joe Valvo | Smitha Shankar | Wendy E. Whatney | John L. Johnson | Lynn M Amon | John L. Johnson | W. H. Boom | Urs A Ochsner | Lynn M Amon
[1] J. Andrews,et al. Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study. , 2017, The Lancet. Respiratory medicine.
[2] V. Bagheri. S100A12: Friend or foe in pulmonary tuberculosis? , 2017, Cytokine.
[3] Jason A. Skinner,et al. Early Whole Blood Transcriptional Signatures Are Associated with Severity of Lung Inflammation in Cynomolgus Macaques with Mycobacterium tuberculosis Infection , 2016, The Journal of Immunology.
[4] Peter J Dodd,et al. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling , 2016, PLoS medicine.
[5] John L. Johnson,et al. Bacillus Calmette–Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses , 2016, The Journal of Immunology.
[6] J. Ernst,et al. The Mechanism for Type I Interferon Induction by Mycobacterium tuberculosis is Bacterial Strain-Dependent , 2016, PLoS pathogens.
[7] J. Flynn,et al. Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography , 2016, Nature Medicine.
[8] J. Dziadek,et al. Mycobacterial antigen 85 complex (Ag85) as a target for ficolins and mannose-binding lectin. , 2016, International journal of medical microbiology : IJMM.
[9] Garnet Navarro,et al. Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial , 2016, EBioMedicine.
[10] M. Tameris,et al. T-cell activation is an immune correlate of risk in BCG vaccinated infants , 2016, Nature Communications.
[11] Daniel E. Zak,et al. A prospective blood RNA signature for tuberculosis disease risk , 2016, The Lancet.
[12] H. Virgin,et al. The Cytosolic Sensor cGAS Detects Mycobacterium tuberculosis DNA to Induce Type I Interferons and Activate Autophagy. , 2015, Cell host & microbe.
[13] Zhijian J. Chen,et al. Cyclic GMP-AMP Synthase Is an Innate Immune DNA Sensor for Mycobacterium tuberculosis. , 2015, Cell host & microbe.
[14] Jonathan L. Schmid-Burgk,et al. Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1. , 2015, Cell host & microbe.
[15] T. Scriba,et al. T cells and adaptive immunity to Mycobacterium tuberculosis in humans , 2015, Immunological reviews.
[16] Bjoern Peters,et al. Transcriptional Profile of Tuberculosis Antigen–Specific T Cells Reveals Novel Multifunctional Features , 2014, The Journal of Immunology.
[17] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[18] John L. Johnson,et al. Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults. , 2014, Vaccine.
[19] V. Holers. Complement and its receptors: new insights into human disease. , 2014, Annual review of immunology.
[20] Michael Levin,et al. Detection of Tuberculosis in HIV-Infected and -Uninfected African Adults Using Whole Blood RNA Expression Signatures: A Case-Control Study , 2013, PLoS medicine.
[21] A. Sher,et al. Influenza A Virus Impairs Control of Mycobacterium tuberculosis Coinfection Through a Type I Interferon Receptor–Dependent Pathway , 2013, The Journal of infectious diseases.
[22] John L. Johnson,et al. Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment , 2013, PloS one.
[23] Scott R. Presnell,et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. , 2013, Immunity.
[24] T. Graeber,et al. Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses , 2013, Science.
[25] Robert J Wilkinson,et al. The immune response in tuberculosis. , 2013, Annual review of immunology.
[26] A. Regev,et al. Dynamic regulatory network controlling Th17 cell differentiation , 2013, Nature.
[27] J. D’Armiento,et al. Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases. , 2012, American journal of respiratory and critical care medicine.
[28] Stefan H. E. Kaufmann,et al. Common patterns and disease-related signatures in tuberculosis and sarcoidosis , 2012, Proceedings of the National Academy of Sciences.
[29] John P. Ray,et al. Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections , 2012, Cell.
[30] Davis J. McCarthy,et al. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.
[31] A. Diacon,et al. Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis , 2011, Tuberculosis.
[32] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[33] T. Shiomi,et al. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. , 2011, The Journal of clinical investigation.
[34] Alimuddin Zumla,et al. Immunological biomarkers of tuberculosis , 2011, Nature Reviews Immunology.
[35] M. Goodell,et al. Inflammatory signals regulate hematopoietic stem cells. , 2011, Trends in immunology.
[36] Virginia Pascual,et al. An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.
[37] Tracy R. Keeney,et al. Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, PloS one.
[38] David M. Tobin,et al. The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans , 2010, Cell.
[39] Serban Nacu,et al. Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..
[40] M. Quail,et al. Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium , 2010, Science.
[41] J. Flynn,et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.
[42] Jianping Jin,et al. IFN-β Inhibits Human Th17 Cell Differentiation1 , 2009, The Journal of Immunology.
[43] A. Diacon,et al. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis. , 2009, Cytokine.
[44] Gerhard Walzl,et al. Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report , 2009, BMC pulmonary medicine.
[45] H. Tilg,et al. Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression? , 2009, European Cytokine Network.
[46] B. Haynes,et al. Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. , 2008, The Journal of infectious diseases.
[47] A. Krarup,et al. Multiple routes of complement activation by Mycobacterium bovis BCG. , 2008, Molecular immunology.
[48] G. Cheng,et al. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. , 2008, The Journal of clinical investigation.
[49] S. Akira,et al. ASK1‐p38 MAPK‐p47phox activation is essential for inflammatory responses during tuberculosis via TLR2‐ROS signalling , 2008, Cellular microbiology.
[50] A. Tunkel. Dexamethasone for treatment of tuberculous meningitis in adolescents and adults , 2005, Current infectious disease reports.
[51] H. Reuter,et al. Cytokine production in patients with tuberculous pericarditis. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[52] J. Ellner,et al. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. , 1994, Journal of immunology.
[53] J. Abrams,et al. Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.
[54] M. Horwitz,et al. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.
[55] T. Clark,et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. , 2013, The Journal of infectious diseases.
[56] P. Klenerman,et al. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[57] Sandra Romero-Steiner,et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines , 2022 .